Healthcare Infrastructure, Operations & Supply Chain

Pharma Packaging Firm Selects Kneat Platform

kneat.com, inc. (TSX: KSI) (OTCQX: KSIOF), the global leader in digital validation and quality process automation, today announced it has signed a Master Services Agreement with a U.S.-headquartered global pharmaceutical packaging and drug-delivery manufacturer.

This new customer operates more than 45 manufacturing facilities worldwide, including over a dozen GMP-regulated sites, and employs over 13,000 people across the United States, Europe, Asia, and South America.

Under the agreement, the customer will initially deploy Kneat Gx for Commissioning, Qualification, and Validation (CQV). Implementation will begin at its lead site, followed by subsequent expansion to all other GMP sites.

A defining factor in this win is the Kneat platform’s robust data integrity capability, which ensures every compliance action and documented outcome is fully attributable, traceable, and audit-ready, aligning with regulatory expectations.

“Regulated manufacturers increasingly rely on Kneat because of its trusted system of record for validation, built to support the highest standards of data integrity and compliance. We’re excited to partner with this global leader as they continue to strengthen their quality and manufacturing excellence.”  

– Eddie Ryan, CEO, Kneat

As life sciences companies modernize their quality systems, structured and verifiable data is a foundational requirement. Kneat’s architecture is purpose-built for this, supporting speed and efficiency while maintaining the strict data integrity and compliance standards required in regulated environments. This strong foundation ensures Kneat remains a stable and indispensable component of customers’ digital operations, even as technology landscapes evolve.

Kneat continues to see broad adoption and expansion across leading pharmaceutical, biotechnology, medical device, and supply-chain manufacturing organizations. This second strategic win of 2026 reinforces Kneat’s role as the recognized standard for digital validation and underscores the long-term relevance and resilience of its data integrity platform.

Related posts

Resonetics to Acquire Resolution Medical in Heart & Neuromodulation

PR Newswire

Hansa Biopharma’s BLA for Imlifidase Accepted by FDA

PR Newswire

Logical Biological Launches Logical Antigen for IVD Market

Business Wire